相似文献
1
Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism.
J Neuroimmune Pharmacol. 2011 Jun;6(2):284-95. doi: 10.1007/s11481-011-9274-7. Epub 2011 Mar 29.
2
The functional roles of lipid rafts in T cell activation, immune diseases and HIV infection and prevention.
Cell Mol Immunol. 2008 Feb;5(1):1-7. doi: 10.1038/cmi.2008.1.
3
Lipids and membrane microdomains in HIV-1 replication.
Virus Res. 2009 Aug;143(2):162-76. doi: 10.1016/j.virusres.2009.04.007. Epub 2009 Apr 19.
4
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure.
Front Immunol. 2018 Sep 4;9:1983. doi: 10.3389/fimmu.2018.01983. eCollection 2018.
5
Role of lipids in virus replication.
Cold Spring Harb Perspect Biol. 2011 Oct 1;3(10):a004820. doi: 10.1101/cshperspect.a004820.
6
HIV: a raft-targeting approach for prevention and therapy using plant-derived compounds (review).
Curr Drug Targets. 2009 Jan;10(1):51-9. doi: 10.2174/138945009787122851.
7
Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.
Virology. 2007 Mar 30;360(1):27-35. doi: 10.1016/j.virol.2006.10.011. Epub 2006 Nov 13.
8
Virus maturation as a new HIV-1 therapeutic target.
Expert Opin Ther Targets. 2009 Aug;13(8):895-908. doi: 10.1517/14728220903039714.
9
Virus assembly and plasma membrane domains: which came first?
Virus Res. 2013 Feb;171(2):332-40. doi: 10.1016/j.virusres.2012.08.014. Epub 2012 Sep 16.
10
Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
J Virol. 2002 May;76(10):4709-22. doi: 10.1128/jvi.76.10.4709-4722.2002.
引用本文的文献
1
Mendelian randomization study of lipid species reveals causal relationship with syphilis.
AMB Express. 2025 Apr 9;15(1):63. doi: 10.1186/s13568-025-01873-x.
2
Metabolomic Profiling Reveals Potential Biomarkers and Prominent Features in HIV/AIDS Patients Co-Infected with SARS-CoV-2.
Microorganisms. 2025 Jan 13;13(1):144. doi: 10.3390/microorganisms13010144.
3
Immunometabolic interference between cancer and COVID-19.
Front Immunol. 2023 Mar 29;14:1168455. doi: 10.3389/fimmu.2023.1168455. eCollection 2023.
4
Cell signaling pathways and HIV-1 therapeutics.
J Neuroimmune Pharmacol. 2011 Jun;6(2):173-6. doi: 10.1007/s11481-011-9275-6. Epub 2011 Mar 30.
本文引用的文献
1
An X-ray diffraction study of model membrane raft structures.
FEBS J. 2010 Nov;277(22):4685-98. doi: 10.1111/j.1742-4658.2010.07875.x. Epub 2010 Oct 11.
2
The Role of Lipids in Retrovirus Replication.
Viruses. 2010 May 1;2(5):1146-1180. doi: 10.3390/v2051146.
3
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.
Chem Biol. 2010 Jul 30;17(7):766-75. doi: 10.1016/j.chembiol.2010.05.023.
4
Greasing their way: lipid modifications determine protein association with membrane rafts.
Biochemistry. 2010 Aug 3;49(30):6305-16. doi: 10.1021/bi100882y.
5
Lipid microdomains: structural correlations, fluctuations, and formation mechanisms.
Phys Rev Lett. 2010 Mar 19;104(11):118101. doi: 10.1103/PhysRevLett.104.118101. Epub 2010 Mar 17.
6
Relationships between plasma membrane microdomains and HIV-1 assembly.
Biol Cell. 2010 Mar 25;102(6):335-50. doi: 10.1042/BC20090165.
7
HIV-1 gp41 fusion intermediate: a target for HIV therapeutics.
J Formos Med Assoc. 2010 Feb;109(2):94-105. doi: 10.1016/S0929-6646(10)60029-0.
8
HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.
Future Virol. 2009;4(3):241-257. doi: 10.2217/fvl.09.4.
9
A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation.
Cell Physiol Biochem. 2009;24(3-4):219-30. doi: 10.1159/000233248. Epub 2009 Aug 3.
10
New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production.
J Lipid Res. 2010 Feb;51(2):286-96. doi: 10.1194/jlr.M000372. Epub 2009 Aug 4.
Zotero 插件